{"filing":{"accession_number":"0001628280-26-042846","cik":"0001736730","ticker":"CAMP","company_name":"Camp4 Therapeutics Corp","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"camp-20260610.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1736730/000162828026042846/camp-20260610.htm"},"events":[{"id":10845,"run_id":9514,"accession_number":"0001628280-26-042846","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Camp4 held its Annual Meeting of Stockholders on June 10, 2026, with shareholders voting on three proposals: election of three Class II directors (Steven Holtzman, Murray Stewart, and Richard Young), ratification of Ernst \u0026 Young LLP as independent auditor, and approval of an amendment to the 2024 Equity Incentive Plan to modify the evergreen provision to include pre-funded warrants in the share calculation. All three proposals passed with detailed vote tallies disclosed.","company_name":"Camp4 Therapeutics Corp","ticker":"CAMP","filing_date":"2026-06-12","form":"8-K","submitted_at":null,"items":[{"id":7263,"accession_number":"0001628280-26-042846","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on two equity plan actions: (1) stockholder approval of an amendment to the 2024 Equity Incentive Plan modifying the evergreen provision to include pre-funded warrants in the share calculation, and (2) Board adoption of a new 2026 Inducement Plan authorizing up to 500,000 shares for non-statutory stock options and other equity awards to new and rehired employees. Both are compensatory arrangements affecting the registrant's equity structure and future grant capacity, fitting the exec_compensation category under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:21:28.841735+00:00","company_name":"","ticker":null,"filing_date":""},{"id":7264,"accession_number":"0001628280-26-042846","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Camp4's June 10, 2026 Annual Meeting, covering three proposals: election of Class II directors (Steven Holtzman, Murray Stewart, and Richard Young), ratification of Ernst \u0026 Young LLP as independent auditor, and approval of an amendment to the 2024 Equity Incentive Plan. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the hallmark of Item 5.07 disclosure and constitute material information about governance and compensation matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:21:28.841735+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7263,"accession_number":"0001628280-26-042846","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on two equity plan actions: (1) stockholder approval of an amendment to the 2024 Equity Incentive Plan modifying the evergreen provision to include pre-funded warrants in the share calculation, and (2) Board adoption of a new 2026 Inducement Plan authorizing up to 500,000 shares for non-statutory stock options and other equity awards to new and rehired employees. Both are compensatory arrangements affecting the registrant's equity structure and future grant capacity, fitting the exec_compensation category under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:21:28.841735+00:00","company_name":"Camp4 Therapeutics Corp","ticker":"CAMP","filing_date":"2026-06-12"},{"id":7264,"accession_number":"0001628280-26-042846","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Camp4's June 10, 2026 Annual Meeting, covering three proposals: election of Class II directors (Steven Holtzman, Murray Stewart, and Richard Young), ratification of Ernst \u0026 Young LLP as independent auditor, and approval of an amendment to the 2024 Equity Incentive Plan. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the hallmark of Item 5.07 disclosure and constitute material information about governance and compensation matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T02:21:28.841735+00:00","company_name":"Camp4 Therapeutics Corp","ticker":"CAMP","filing_date":"2026-06-12"}]}